Idexx Laboratories (IDXX) Debt to Equity (2009 - 2026)

Idexx Laboratories' Debt to Equity history runs 18 years deep, the most recent figure standing at $0.53 for Q1 2026.

• In Q1 2026, Debt to Equity rose 24.4% year-over-year to $0.53; the TTM figure through Mar 2026 stood at $0.53 (up 24.4% YoY), while the FY2025 annual figure was $0.28, down 36.12% from the prior year.
• Debt to Equity was $0.53 for Q1 2026 at Idexx Laboratories, up from $0.28 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $3.02 in Q2 2022 to a low of $0.28 in Q4 2025.
• Historically, Debt to Equity has averaged $0.94 across 5 years, with a median of $0.56 in 2024.
• The sharpest annual moves came in 2022 and 2023: Debt to Equity soared 159.33% in 2022, then slumped 79.76% in 2023.
• A 5-year view of Debt to Equity shows it stood at $1.55 in 2022, then slumped by 69.7% to $0.47 in 2023, then decreased by 6.69% to $0.44 in 2024, then tumbled by 36.12% to $0.28 in 2025, then soared by 90.32% to $0.53 in 2026.
• The last three Debt to Equity figures came in at $0.53 (Q1 2026), $0.28 (Q4 2025), and $0.53 (Q3 2025), per Business Quant data.